Mesacol OD 1200mg – Affordable Lialda Alternative

Name: Mesacol OD 1200 mg
Brand: Lialda
SKU: 2627
Availability: InStock

Mesacol OD1200 mg for oral administration is an extended-release formulation of mesalamine, an anti-inflammatory agent for gastrointestinal use. It treats and maintains remission in Crohn’s disease and ulcerative colitis. Mesacol OD1200 mg for oral administration is an extended-release formulation of mesalamine, an anti-inflammatory agent for gastrointestinal use is delivered in the intestine due to the controlled release tablet. It contains the active ingredient Mesalazine, which prevents or blocks the production of certain substances responsible for causing inflammation. Mesalazine helps to reduce symptoms such as bleeding, diarrhea, and stomach pain by reducing the inflammation in the bowel.

Precautions

Mesacol OD1200 mg is contraindicated in patients with known or suspected hypersensitivity to salicylates, aminosalicylates, or any components of this medicine. Avoid using the medicine if you have experienced an allergic reaction while taking sulfasalazine. Inform your healthcare provider of liver problems, kidney diseases, asthma, or heart problems. You may develop kidney stones while on treatment with this medication. Therefore, you should drink plenty of water.

Mesacol OD1200 mg tablets should be used with caution in pregnant and breastfeeding women only if it is required. It is not recommended for use in children and adolescents aged below 18 years of age. It is advised to use it with caution in elderly patients.

You need to be cautious while simultaneously taking this medication, along with medicines like Azathioprine, thioguanine (used in cancer treatment), and 6-mercaptopurine. Mesalazine, when combined with blood thinners like warfarin, may reduce the effect of warfarin.

Mesacol 1200 mg passes into the breast milk. When prescribed, watch out for symptoms like diarrhea; if your child develops it immediately, discontinue breastfeeding and speak to your doctor.

Dosage Instructions

Side Effects

Most people can tolerate Mesacol OD 1200 mg well. If you have problems with less serious side effects, get immediate medical help. Often, side effects such as diarrhea, nausea, mild hair loss, and abdominal pain lessen and resolve with time or decrease.

Speak to your health care specialist right away if you have any of these side effects, such as chest pain, jaundice, shortness of breath, skin rash, and change in the frequency of urination. Some people may get a severe allergic reaction that requires urgent medical attention. Seek immediate medical help if you develop symptoms like swelling of the face, tongue, throat, bruising, unusual bleeding, excessive tiredness, rash, fever, and sore throat.

How to Use

The dose will depend on what you are being treated for; therefore, using the medicines only as your healthcare provider prescribes is important. In general, Mesacol OD 1200mg may be taken with food or an empty stomach. Swallow the tablet with a glass full of water, preferably before your meals. Do not break, cut, or chew the medicine. It is best to take it at a fixed time for optimal results, and you should not consume more than the health care specialist prescribes. Drink an adequate amount of fluids. You should keep on taking the medicine as prescribed. If you stop treatment too early, your symptoms may return, and your condition may worsen. The safety and effectiveness of this medicine in pediatric patients have not been established.

Infographics

FAQ

What is Mesalazine Prolonged Release and what condition does it treat?

Mesalazine Prolonged Release is an anti-inflammatory medication used to treat ulcerative colitis, a chronic bowel disease causing inflammation and ulcers in the colon and rectum. Available as Mesacol OD 1200mg tablets, this aminosalicylate medicine works directly in the gut lining to reduce inflammation. The prolonged release formulation delivers the active ingredient mesalazine gradually throughout the digestive tract, allowing once-daily dosing for convenient inflammatory bowel disease management. This treatment helps control symptoms like bloody diarrhoea, abdominal pain, and urgency while maintaining remission in ulcerative colitis patients.

How does Mesalazine Prolonged Release work in the body?

Mesalazine Prolonged Release works by delivering the active anti-inflammatory compound directly to inflamed tissues in the colon. The prolonged release coating on Mesacol OD 1200mg ensures mesalazine is released slowly as the tablet passes through your digestive system, targeting the lower bowel where ulcerative colitis inflammation occurs. Once released, this aminosalicylate medication inhibits inflammatory chemicals called prostaglandins and leukotrienes that damage the gut lining. By blocking these inflammation pathways locally in the intestinal wall, the medicine reduces swelling, ulceration, and bleeding without suppressing your entire immune system like steroids do.

How long does Mesacol OD 1200mg take to work?

Mesacol OD 1200mg typically begins working within three to five days, though noticeable symptom improvement in ulcerative colitis often takes two to four weeks. The prolonged release formulation of mesalazine delivers medication gradually, meaning peak effectiveness builds over time rather than immediately. Some patients report reduced bleeding and bowel urgency within the first week, while complete inflammation control may require six to eight weeks of consistent use. Response times vary depending on disease severity and individual factors. For maintaining remission in inflammatory bowel disease, the anti-inflammatory benefits continue as long as you take this aminosalicylate medication regularly.

When and how should I take Mesacol OD 1200mg?

Take Mesacol OD 1200mg once daily, preferably at the same time each day with or without food. Swallow the prolonged release tablet whole with water—never crush, chew, or break it, as this destroys the special coating that delivers mesalazine throughout your digestive tract. Many patients find taking it with breakfast helps establish a consistent routine for their ulcerative colitis treatment. If you miss a dose, take it as soon as you remember unless it's nearly time for your next dose. Your doctor will determine the appropriate duration based on your inflammatory bowel disease condition and response to this aminosalicylate therapy.

Is Mesacol OD 1200mg safe for long-term use?

Mesacol OD 1200mg is generally considered safe for long-term use in managing ulcerative colitis, with many patients taking this aminosalicylate medication for years to maintain remission. The prolonged release mesalazine formulation works locally in the gut rather than systemically, resulting in fewer long-term risks compared to steroids or immunosuppressants used for inflammatory bowel disease. Most patients tolerate extended treatment well, though periodic monitoring through blood tests and kidney function checks helps ensure continued safety. Long-term use has proven effective in preventing ulcerative colitis flare-ups and reducing the need for stronger medications or surgery in many individuals.

Can I take Mesacol OD 1200mg with other medicines?

Mesacol OD 1200mg can generally be taken alongside most medications, though some interactions require caution. Azathioprine or mercaptopurine, other inflammatory bowel disease treatments, may interact with mesalazine and need monitoring. NSAIDs like ibuprofen might worsen ulcerative colitis symptoms and reduce effectiveness of this aminosalicylate medication. Antacids can affect the prolonged release coating, so space them at least two hours apart. Warfarin users may need adjusted monitoring. Always inform healthcare providers about all medications, supplements, and over-the-counter products you're taking to avoid potential interactions with your ulcerative colitis treatment regimen.

How does Mesacol OD 1200mg compare to similar medicines in its class?

Mesacol OD 1200mg offers convenient once-daily dosing compared to older mesalazine formulations requiring multiple daily doses for ulcerative colitis management. Unlike sulfasalazine, another aminosalicylate, this prolonged release mesalazine doesn't contain sulfa components that cause allergic reactions in some patients. Compared to balsalazide or olsalazine alternatives, Mesacol OD delivers the active anti-inflammatory ingredient directly rather than requiring bacterial conversion in the colon. The 1200mg strength provides effective inflammatory bowel disease control in a single tablet, improving treatment adherence. While all mesalazine products share similar effectiveness, the prolonged release technology and dosing convenience distinguish this formulation.

Is the generic Mesalazine Prolonged Release as effective as branded versions?

Generic Mesalazine Prolonged Release demonstrates equivalent effectiveness to branded versions like Mesacol OD 1200mg for treating ulcerative colitis. Regulatory agencies in the USA, UK, Australia, and Canada require generic aminosalicylate medications to contain identical active ingredients and meet the same bioequivalence standards as branded formulations. Clinical studies confirm generic mesalazine products deliver comparable anti-inflammatory effects in inflammatory bowel disease management. The prolonged release technology functions identically whether branded or generic. Choosing generic options can offer significant cost savings while maintaining the same therapeutic benefits for controlling ulcerative colitis symptoms and preventing flare-ups.

Why do patients choose PremiumRxDrugs for Mesacol OD 1200mg?

Patients choose PremiumRxDrugs for Mesacol OD 1200mg because of reliable access to authentic mesalazine medications combined with competitive pricing on ulcerative colitis treatments. As a licensed pharmacy with over ten years of trusted service across the USA, UK, Australia, and Canada, we guarantee manufacturer-sourced aminosalicylate products. The platform offers convenient prescription management and easy reordering for ongoing inflammatory bowel disease maintenance therapy. Discreet packaging respects privacy while worldwide shipping with free delivery options makes prolonged release mesalazine accessible regardless of location. Patients value the combination of pharmaceutical authenticity, affordability, and customer-focused service for managing their long-term ulcerative colitis medication needs.

What are the common side effects of Mesalazine Prolonged Release?

Common side effects of Mesalazine Prolonged Release include headache, nausea, abdominal pain, diarrhoea, and indigestion affecting some ulcerative colitis patients. Less frequent reactions involve rash, joint pain, dizziness, or tiredness. Most aminosalicylate side effects are mild and temporary as your body adjusts to the anti-inflammatory medication. Rare but serious effects include kidney problems, blood disorders, pancreatitis, or worsening colitis symptoms requiring immediate medical attention. Some patients experience hair loss or fever. The prolonged release formulation may cause fewer gastrointestinal complaints compared to immediate-release versions. Reporting unusual symptoms helps healthcare providers optimize your inflammatory bowel disease treatment safely.

Who should avoid taking Mesalazine Prolonged Release?

People with severe kidney or liver disease should avoid Mesalazine Prolonged Release as this aminosalicylate medication is processed through these organs. Those allergic to mesalazine, aspirin, or salicylates shouldn't use this ulcerative colitis treatment due to potential severe reactions. Patients with active stomach ulcers or blood clotting disorders require careful evaluation before starting this anti-inflammatory therapy. Pregnancy and breastfeeding require medical consultation, though mesalazine is sometimes used when benefits outweigh risks. Children under specific ages may need alternative formulations. Anyone with a history of pericarditis or myocarditis linked to previous aminosalicylate use should avoid this inflammatory bowel disease medication and discuss alternative treatments.

SKU	2627
Generic For	Lialda
Manufacturer	Sun Pharmaceuticals Ltd
Active Ingredient	Mesalazine Prolonged Release